Credit Suisse Slashes Edge Therapeutics Price Target By 94%, Downgrades Stock After Failed Trial

Elizabeth Balboa

Thu, Mar 29, 2018, 11:32 AM

Edge Therapeutics Inc (NASDAQ: EDGE) closed down 87 percent Wednesday and continued to decline Thursday after announcing layoffs, the discontinuation of its Phase 3 NEWTON 2 study and the evaluation of its next steps.

Even now, Credit Suisse considers Edge overvalued.

The Rating

Analyst Martin Auster downgraded the stock from Outperform to Underperform and bulldozed the price target from $17 to $1.

The Thesis

Edge announced that interim data for a treatment of aneurysmal subarachnoid hemorrhages has a low probability of achieving statistical significance compared to the standard of care, according to Credit Suisse.

As Edge has no other products in clinical development, this effectively eliminates its immediate revenue opportunity.

The best case scenario is a $2 valuation, Auster said. The worst case: zero.

"Our grey sky valuation of zero assumes that EDGE spends through its remaining cash and is unable to obtain additional funding," Auster said.

Despite continued cash burn for severance packages and trial closure costs, reductions in both R&D and general and administrative expenses are seen to improve the firm’s bottom-line prospects this year. Credit Suisse anticipates a 2018 loss per share of $1.45 against prior estimates of $2.21.

Price Action

Edge Therapeutics shares were down 6.5 percent at the time of publication Thursday.

Related Links:

Cantor Fitzgerald Names 8 Upcoming Biotech Catalysts

For Now, Traders Endorse Biotech Rally

Latest Ratings for EDGE

Mar 2018	Credit Suisse	Downgrades	Outperform	Underperform
May 2016	Credit Suisse	Maintains		Outperform
Mar 2016	Leerink Swann	Maintains		Outperform

View More Analyst Ratings for EDGE
View the Latest Analyst Ratings

See more from Benzinga

Mark Zuckerberg got $24.4 million in ‘other compensation’ in 2023—but Meta also treated staff well, with the median employee making $379,000
On paper, Mark Zuckerberg is Meta’s lowest-paid employee, with a $1 dollar salary and no bonus.
Fortune•1d ago
The Fed's Key Inflation Rate Sizzles As GDP Slows; S&P 500 Futures Slide
The key Federal Reserve inflation rate, the core PCE price index, reared up in Q1 as GDP grew at a slower pace.
Investor's Business Daily•22m ago
$433 Billion Gone! One Stock Loses More Value Than Tesla
Tesla's loss of $328.3 billion this year in stock value certainly hurts. But it's only the second-largest market value loss in the S&P 500.
Investor's Business Daily•1d ago
Stock market today: US stocks tumble after Meta's reality check, soft GDP print
Meta's AI reality check has dented hopes for a Big Tech revival for stocks, with a GDP update showing the US economy grew slower than expected in the first quarter.
Yahoo Finance•1m ago
The Vanguard 500 Index Fund Is Great, But Another Vanguard ETF Has Outperformed It the Past Decade
This growth ETF has nicely outperformed the S&P 500 since its inception.
Motley Fool•3h ago
Bitcoin Just Did Something It Has Only Done 3 Times Before. The Cryptocurrency Usually Does This Next.
Bitcoin block subsidies were recently reduced by half for the fourth time in history, and halving events have always led to significant price appreciation.
Motley Fool•4h ago
China's Temu Takes Over 17% Of US Market Share, Cutting Jobs From American Amazon And Decimating Small Businesses
With rising inflation, American consumers are increasingly turning to the Chinese e-commerce platform Temu for their shopping needs. With its enticing tagline “Shop like a billionaire,” Temu has captured 17% of the U.S. market share, posing a challenge to traditional American retailers such as Amazon.com Inc., Dollar Tree Inc. and Five Below Inc. The rise highlights the lucrative and disruptive nature of startups. Owned and operated by PDD Holdings Inc. (NASDAQ:PDD), Temu offers a wide range of
Benzinga•17h ago
One Member of Congress Is Going Against the Grain and Selling This Skyrocketing Stock-Split Stock
One of Capitol Hill's most-active stock traders is sending a company with well-defined competitive advantages -- that also happens to be on the verge of its first-ever stock split -- to the chopping block.
Motley Fool•4h ago
Analysts reset Microsoft stock price targets ahead of highly anticipated earnings
Microsoft, which overtook Apple as the world's most valuable company earlier this year, is looking to cement its AI market leadership.
TheStreet•14h ago
Altria tops first quarter sales on higher pricing, robust demand for smokeless alternatives
Like other tobacco giants, Altria has been revamping its portfolio of products to keep up with consumers switching from traditional tobacco products to vapes or other alternatives and as inflation-hit smokers switched to cheaper brands. The company's net revenue came in at $5.58 billion in the first quarter, topping analyst expectations of $4.71 billion, while profit on an adjusted basis came in line with expectations. Last year, Altria launched a lower-priced version of its flagship Marlboro brand and finalized its acquisition of e-cigarette startup NJOY Holdings, expanding its portfolio to include pod-based vapes.
Reuters•1h ago

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Credit Suisse Slashes Edge Therapeutics Price Target By 94%, Downgrades Stock After Failed Trial

Recommended Stories

Mark Zuckerberg got $24.4 million in ‘other compensation’ in 2023—but Meta also treated staff well, with the median employee making $379,000

The Fed's Key Inflation Rate Sizzles As GDP Slows; S&P 500 Futures Slide

$433 Billion Gone! One Stock Loses More Value Than Tesla

Stock market today: US stocks tumble after Meta's reality check, soft GDP print

The Vanguard 500 Index Fund Is Great, But Another Vanguard ETF Has Outperformed It the Past Decade

Bitcoin Just Did Something It Has Only Done 3 Times Before. The Cryptocurrency Usually Does This Next.

China's Temu Takes Over 17% Of US Market Share, Cutting Jobs From American Amazon And Decimating Small Businesses

One Member of Congress Is Going Against the Grain and Selling This Skyrocketing Stock-Split Stock

Analysts reset Microsoft stock price targets ahead of highly anticipated earnings

Altria tops first quarter sales on higher pricing, robust demand for smokeless alternatives